Rend Al-Mondhiry Quoted in “DEA ‘Synthetic Cannabinoid’ Statements Raise Concerns for CBD Stakeholders”
Rend Al-Mondhiry spoke with Natural Products Insider about a DEA proposal to regulate synthetic cannabinoids and how it could affect the CBD market.
Rend stated that the delta-8 THC issue has been festering since the molecule went on the market in significant quantities several years ago, and it was not a surprise that the DEA may address it.
To read the full story, click here.